Largest biotech companies in the United States by cash on hand

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Amgen leads the 20 biotech companies in the United States ranked by cash on hand, at $9.1B, ahead of Gilead Sciences ($7.6B) and Biogen ($3B). Figures as of 20 Nov 2026, 03:22 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
20
First
Amgen$9.1B
Median
$370.4M
Combined market value
$734.9B
Countries
1

Market values as of .

United States
All sectors
Biotech
USD
Clear filters
Largest biotech companies in the United States by cash on hand
#CompanyCash on hand ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health Care$9.1B$237.4B$438.82 1.14% down 32% up United States
2Gilead SciencesGILD · Health Care$7.6B$206.6B$166.53 1.45% down 35% up United States
3BiogenBIIB · Health Care$3B$36.5B$247.13 1.70% down 49% up United States
4ModernaMRNA · Health Care$2.6B$80.7B$199.33 1.29% up 780% up United States
5ImmunovantIMVT · Health Care$902.1M$6.7B$32.52 1.96% down 46% up United States
6Neurocrine BiosciencesNBIX · Health Care$713M$15.8B$156.59 3.85% down 17% up United States
7RepligenRGEN · Health Care$566M$10.9B$170.29 1.38% down 12% up United States
8Krystal BiotechKRYS · Health Care$496.3M$9.4B$315.82 0.15% up 54% up United States
9ExelixisEXEL · Health Care$482.5M$16.1B$65.83 3.60% down 63% up United States
10Revolution MedicinesRVMD · Health Care$383.7M$34.5B$159.43 0.24% down 129% up United States
11Kymera TherapeuticsKYMR · Health Care$357M$10.2B$119.39 1.44% down 87% up United States
12Scholar Rock HoldingSRRK · Health Care$323.5M$6.1B$50.37 4.94% up 26% up United States
13Bio-TechneTECH · Health Care$264.7M$11.4B$72.70 0.07% down 24% up United States
14Kodiak SciencesKOD · Health Care$209.9M$6.4B$97.90 0.09% up 399% up United States
15Twist BioscienceTWST · Health Care$183M$7.6B$111.62 4.07% down 346% up United States
16VaxcytePCVX · Health Care$174M$9.2B$58.36 0.27% down 23% up United States
17Halozyme TherapeuticsHALO · Health Care$133.8M$10.6B$93.04 2.88% down 39% up United States
18ImmunityBioIBRX · Health Care$88.3M$7B$6.57 1.94% down 232% up United States
19Adaptive BiotechnologiesADPT · Health Care$70.5M$4.5B$28.05 1.44% down 74% up United States
20CG OncologyCGON · Health Care$32.5M$7.3B$81.90 2.38% up 97% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period.

Questions and answers

Which biotech companies in the United States rank first by cash on hand?

Amgen ($9.1B), Gilead Sciences ($7.6B) and Biogen ($3B) are the top three of the 20 biotech companies in the United States ranked by cash on hand as of 20 Nov 2026, 03:22 UTC.

How many biotech companies in the United States are in this ranking?

20 are ranked by cash on hand.

What are these biotech companies in the United States worth together?

The 20 biotech companies in the United States ranked by cash on hand have a combined market value of $734.9B as of 20 Nov 2026, 03:22 UTC.

What does ranking by cash on hand measure?

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Cite this page

Funkfolio, “Largest biotech companies in the United States by cash on hand”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=cash-on-hand

Underlying data: Yahoo Finance; SEC EDGAR.